Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the breast cancer family registry

Carcinogenesis

Volumn 33, Issue 10, 2012, Pages 1946-1952

  Wu, Hui Chen ^a   Delgado Cruzata, Lissette ^a   Flom, Julie D ^a   Perrin, Mary ^b   Liao, Yuyan ^a   Ferris, Jennifer S ^a   Santella, Regina M ^a,c   Terry, Mary Beth ^a,c  

^a Mailman School of Public Health of Columbia University ^*  (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

ADULT; ALU SEQUENCE; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GRANULOCYTE; HUMAN; INTERSPERSED REPEAT; LEUKOCYTE COUNT; LONG INTERSPERSED REPEAT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PYROSEQUENCING; SEQUENCE ANALYSIS;

BREAST NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; LEUKOCYTES; REGISTRIES; REPETITIVE SEQUENCES, NUCLEIC ACID; RISK FACTORS; SIBLINGS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864793380     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs201     Document Type: Article

References (48)

1. Dumitrescu, R.G. et al. (2005) Understanding breast cancer risk - where do we stand in 2005? J. Cell. Mol. Med., 9, 208-221.
2. Herceg, Z. (2007) Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis, 22, 91-103.
3. Jones, P.A. et al. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
4. Ehrlich, M. (2002) DNA methylation in cancer: too much, but also too little. Oncogene, 21, 5400-5413.
5. Tycko, B. (2003) Genetic and epigenetic mosaicism in cancer precursor tissues. Ann. N. Y. Acad. Sci., 983, 43-54.
6. Frühwald, M.C. et al. (2002) Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential. Mol. Genet. Metab., 75, 1-16.
7. Lander, E.S. et al.; International Human Genome Sequencing Consortium. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
8. Yu, F. et al. (2001) Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res., 29, 4493-4501.
9. Steinhoff, C. et al. (2004) Transcriptional regulation of the human LINE-1 retrotransposon L1.2B. Mol. Genet. Genom., 270, 394-402.
10. Yoder, J.A. et al. (1997) Cytosine methylation and the ecology of intragenomic parasites. Trends Genet., 13, 335-340.
11. Hoffmann, M.J. et al. (2005) Causes and consequences of DNA hypomethylation in human cancer. Biochem. Cell Biol., 83, 296-321.
12. Laird, P.W. (2003) The power and the promise of DNA methylation markers. Nat. Rev. Cancer, 3, 253-266.
13. Patel, A. et al. (2003) DNA methylation as a cancer-specific biomarker: from molecules to populations. Ann. N. Y. Acad. Sci., 983, 286-297.
14. Moore, L.E. et al. (2008) Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: sa case-control study. Lancet Oncol., 9, 359-366.
15. Cash, H.L. et al. (2012) LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int. J. Cancer, 130, 1151-1159.
16. Lim, U. et al. (2008) Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology, 134, 47-55.
17. Choi, J.Y. et al. (2009) Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis, 30, 1889-1897.
18. Hsiung, D.T. et al. (2007) Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 16, 108-114.
19. Terry, M.B. et al. (2011) DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics, 6, 828-837.
20. Cho, Y.H. et al. (2010) Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res., 30, 2489-2496.
21. Weisenberger, D.J. et al. (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res., 33, 6823-6836.
22. Yang, A.S. et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res., 32, e38.
23. Wu, H.C. et al. (2011) Global methylation profiles in DNA from different blood cell types. Epigenetics, 6, 76-85.
24. John, E.M. et al.; Breast Cancer Family Registry. (2004) The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res., 6, R375-R389.
25. Kennedy, D.O. et al. (2005) DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J. Natl. Cancer Inst., 97, 127-132.
26. Machella, N. et al. (2008) Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR. Carcinogenesis, 29, 1367-1372.
27. Zipprich, J. et al. (2009) Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Cancer Res., 69, 2966-2972.
28. Greenland, S. (1989) Modeling and variable selection in epidemiologic analysis. Am. J. Public Health, 79, 340-349.
29. Zeger, S.L. et al. (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics, 44, 1049-1060.
30. Ehrlich, M. et al. (1982) Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res., 10, 2709-2721.
31. Teschendorff, A.E. et al. (2009) An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS ONE, 4, e8274.
32. Zhu, Z.Z. et al. (2011) Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control, 22, 437-447.
33. Bjornsson, H.T. et al. (2008) Intra-individual change over time in DNA methylation with familial clustering. JAMA, 299, 2877-2883.
34. Fraga, M.F. et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A., 102, 10604-10609.
35. Terry, M.B. et al. (2008) Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol. Biomarkers Prev., 17, 2306-2310.
36. Kim, K.Y. et al. (2010) Association of low-dose exposure to persistent organic pollutants with global DNA hypomethylation in healthy Koreans. Environ. Health Perspect., 118, 370-374.
37. Rusiecki, J.A. et al. (2009) Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health Study. Environ. Health Perspect., 117, 581-586.
38. Pilsner, J.R. et al. (2009) Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ. Health Perspect., 117, 1466-1471.
39. Wright, R.O. et al. (2010) Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ. Health Perspect., 118, 790-795.
40. Bollati, V. et al. (2007) Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res., 67, 876-880.
41. Pavanello, S. et al. (2009) Global and gene-specific promoter methylation changes are related to anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int. J. Cancer, 125, 1692-1697.
42. Nelson, H.H. et al. (2011) Global methylation in exposure biology and translational medical science. Environ. Health Perspect., 119, 1528-1533.
43. Choi, S.H. et al. (2009) Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. Int. J. Cancer, 125, 723-729.
44. Lu, Y.J. et al. (1993) Direct chromosome analysis of 50 primary breast carcinomas. Cancer Genet. Cytogenet., 69, 91-99.
45. Pandis, N. et al. (1995) Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes. Chromosomes Cancer, 12, 173-185.
46. Jackson, K. et al. (2004) DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol. Ther., 3, 1225-1231.
47. Narayan, A. et al. (1998) Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int. J. Cancer, 77, 833-838.
48. Ewing, A.D. et al. (2010) High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res., 20, 1262-1270.